The rise of Sildenafil initially sparked a period of growth for major pharmaceutical companies, however recent shifts present a uncertain outlook for investors. Off-patent competitors are eroding revenue, and ongoing https://estellefgzm189602.mybjjblog.com/sildenafil-and-big-pharma-a-volatile-bet-53360422